Sunshine Biopharma Inc. Common Stock (NASDAQ: SBFM) last traded at $1.16, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Sunshine Biopharma Inc. Common Stock’s own filings and are restated only when a new one is published.
Sunshine Biopharma Inc. Common Stock trades on NASDAQ under the ticker SBFM. Its market capitalisation is $4.50 million.
Valuation measures for Sunshine Biopharma Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.50M |
|---|---|
| P/E ratio | 0.75 |
| Price / sales | 0.13 |
| Price / book | 0.16 |
| Beta | 1.13 |
Trailing-twelve-month figures tagged in Sunshine Biopharma Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $35.35M |
|---|---|
| Net income (TTM) | -$5.83M |
| EPS (TTM) | $1.54 |
| Gross margin | 30.30% |
| Operating margin | -16.65% |
| Return on equity | -21.18% |
Range and volume for SBFM over the past 52 weeks.
| 52-week high | $24.30 |
|---|---|
| 52-week low | $1.03 |
| Volume | 96.6K |
| Average volume | 659.0K |
| Previous close | $1.16 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.